Sign in
4

Changes in Ownership

Cellectar Biosciences, Inc. Filed Acc 0001144204-15-014088

Options or other derivatives

  • VP of Business Development acquired 10,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Genn John Patrick VP of Business Development 2015-02-26 Grant or award · Stock option (right to buy) +10,000 10,000 D
Loading xslF345X03/v403678_4.xml…